Skip to main navigation Skip to search Skip to main content

LBI-2279-004: Single Arm, Open-Label, Multicenter, Registry Study of Revcovi (Elapegademase-Ivir) Treatment in ADA-SCID Patients Requiring Enzyme Replacement Therapy

Project: Research

Project Details

StatusFinished
Effective start/end date10/1/19 → 10/1/23

Funding

  • Leadiant Biosciences Incorporated: $57,960.00